US20120283164A1 - Alpha-Amylase Mutants - Google Patents

Alpha-Amylase Mutants Download PDF

Info

Publication number
US20120283164A1
US20120283164A1 US13/556,623 US201213556623A US2012283164A1 US 20120283164 A1 US20120283164 A1 US 20120283164A1 US 201213556623 A US201213556623 A US 201213556623A US 2012283164 A1 US2012283164 A1 US 2012283164A1
Authority
US
United States
Prior art keywords
alpha
amylase
seq id
g182
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/556,623
Inventor
Allan Svendsen
Torben Vedel Borchert
Henrik Bisgard-Frantzen
Helle Outtrup
Bjarne Ronfeldt Nielsen
Vibeke Skovgaard Neilsen
Lisbeth Hedegaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DK117297 priority Critical
Priority to DK1172/97 priority
Priority to US6330697P priority
Priority to US09/170,670 priority patent/US6187576B1/en
Priority to DKPA199900439 priority
Priority to DK199900439 priority
Priority to US09/290,734 priority patent/US6361989B1/en
Priority to US09/545,586 priority patent/US6528298B1/en
Priority to US10/327,837 priority patent/US7566561B2/en
Priority to US12/493,860 priority patent/US8263368B2/en
Application filed by Novozymes AS filed Critical Novozymes AS
Priority to US13/556,623 priority patent/US20120283164A1/en
Publication of US20120283164A1 publication Critical patent/US20120283164A1/en
Application status is Abandoned legal-status Critical

Links